MetabolismNews.net

Metabolism Xagena

Xagena Mappa
Medical Meeting
Xagena Salute
Reumabase.it

Search results for "Postmenopausal osteoporosis"

The U.S. FDA ( Food and Drug Administration ) approved once- monthly oral Ibandronate ( Boniva ) 150 mg tablets, the first and only once-a-month drug for the treatment of postmenopausal osteoporosis. ...


The data of the phase III study, MOBILE, confirm Bonviva a once-monthly oral treatment for postmenopausal osteoporosis, is highly effective and well tolerated over two years. Bonviva ( Ibandronic ...


Patients who take glucocorticoid drugs ( such as Prednisolone or Prednisone ) to treat a variety of inflammatory/immune-mediated diseases ( such as rheumatoid arthritis or asthma ) can suffer side eff ...


Osteoporosis medications increase bone-mineral density ( BMD ) and lower but do not eliminate fracture risk. The combining of anabolic agents with bisphosphonates has not improved efficacy.Researchers ...